Search results
CD7 expression tied to poorer outcomes with newly diagnosed leukemia
Medical Xpress· 6 days agoCD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid ...
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival:...
Medical Xpress· 20 hours agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Researchers discover new target for potential leukemia therapy
Medical Xpress· 2 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
Morningstar· 4 days agoTC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today ...
Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of...
The Pilot News· 4 days agoDeerfield Management and the Deerfield Foundation announced today they will honor the 2023-2024 recipients of the American Society of Hematology (ASH) Peter Steelman Scholar Award at the second ...
bluebird bio reports first commercial gene therapy use By Investing.com
Investing.com· 4 days agoThis development marks a major step in making the treatment accessible to patients with a history of...
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
NBC 17 Raleigh· 21 hours agoMoleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge - Spirit Airlines (NYSE:SAVE)
Benzinga· 4 days agoEyePoint Pharmaceuticals, Inc EYPT was down, falling 42... More On CNBC’s ‘Final Trades’ Commodities...
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
InvestorPlace· 4 days agoGlycoMimetics (NASDAQ:GLYC) stock is taking a beating on Monday after the biotechnology company announced results from a Phase 3 clinical trial....
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel...